Location History:
- München, DE (2014)
- Munich, DE (2013 - 2015)
Company Filing History:
Years Active: 2013-2015
Title: Lutz Zeitlmann: Innovator in Protein Kinase Inhibitors
Introduction
Lutz Zeitlmann is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for protein kinases. With a total of five patents to his name, Zeitlmann's work is crucial in addressing various medical conditions.
Latest Patents
His latest patents focus on inhibitors of protein kinases, specifically compounds of general Formula (I). These compounds are designed to inhibit members of the cyclin-dependent kinase family and the glycogen synthase kinase 3 family. They are particularly useful in preventing and treating a wide range of health issues, including pain, inflammatory disorders, cancer, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases, metabolic disorders, renal diseases, neurologic and neuropsychiatric diseases, and neurodegenerative diseases. The inhibitors also target cyclin-dependent kinases such as CDK9, showcasing their potential in therapeutic applications.
Career Highlights
Throughout his career, Lutz Zeitlmann has worked with notable companies in the pharmaceutical industry, including Ingenium Pharmaceuticals GmbH and AstraZeneca AB. His expertise in the field has led to advancements in drug development and therapeutic strategies.
Collaborations
Zeitlmann has collaborated with esteemed colleagues such as Hans Allgeier and Martin Augustin, contributing to the innovative research and development of new therapeutic agents.
Conclusion
Lutz Zeitlmann's contributions to the field of protein kinase inhibitors highlight his role as a key innovator in biochemistry. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.